Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2025-12-26 @ 1:55 AM
Study NCT ID:
NCT00954005
Status:
TERMINATED
Last Update Posted:
2015-08-19
First Post:
2009-08-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
Sponsor:
German Low Grade Lymphoma Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-04
First Submit QC Date:
None
Study First Post Date:
2009-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-17
Last Update Post Date:
2015-08-19
Last Update Post Date Type:
ESTIMATED